Clinical Trial Update: Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock [Phase 2]

View source ↗

Summary

Pilot Phase II study assessing hemodynamic tolerance and anti-inflammatory effects of esmolol during treatment of septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Esmolol (esmolol)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Septic Shock | Phase 2 | Status: UNKNOWN